Thalidomide causes platelet activation, which can be abrogated by aspirin [2]

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 6, 2007, Pages 1323-1324

  Dunkley, Scott ^a   Gaudry, L ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PADGEM PROTEIN; PREDNISONE; THALIDOMIDE; WARFARIN;

DISEASE COURSE; DRUG DOSE ESCALATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; FOLLOW UP; HUMAN; LETTER; MONOTHERAPY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 34250174814     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02542.x     Document Type: Letter

References (8)

1. Rajkumar SV. Thalidomide therapy and deep venous thrombosis in multiple myeloma. Mayo Clin Proc 2005; 80: 1549-51.
2. Palumbo A, Rus C, Zeldis JB, Rodeghiero F, Boccadoro M, for the Italian Multiple Myeloma Network, GIMEMA. Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide. J Thromb Haemost 2006; 4: 1842-5.
3. Zangari M, Barlogie B, Anaissie E, Saghafifar F, Eddlemon P, Jacobsen J, Lee CK, Thertulien R, Talamo G, Thomas T, Van Rhee F, Fassas A, Fink L, Tricot G. Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: Effects of prophylactic and therapeutic anticoagulation. Br J Haematol 2004; 126: 715-21.
4. Baz R, Li L, Kotte-Marchant K, Srkalovic G, McGowan B, Yiannaki E, Karam M, Faiman B, Abou Jawed R, Andresen S, Zeldis J, Hussein MA. The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycine-based chemotherapy for multiple myeloma. Mayo Clin Proc 2005; 80: 1568-74.
5. Streetly M, Hunt BJ, Parmar K, Jones R, Zeldis J, Schey S. Markers of endothelial and haemostatic function in the treatment of relapsed myeloma with the immunomodulatory agent Actimid (CC-4047) and their relationship with venous thrombosis. Eur J Haematol 2005; 74: 293-6.
6. Dunkley S, Harrison P. Platelet activation can occur by shear stress alone in the PFA-100 platelet analyser. Platelets 2005; 16: 81-4.
7. Furst R, Blumenthal SB, Kiemer AK, Zahler S, Vollmar AM. Nuclear factor-kappa B- independent anti-inflammatory action of salicylate in human endothelial cells: Induction of heme oxygenase-1 by the c-jun N-terminal kinase/activator protein-1 pathway. J Pharmacol Exp Ther 2006; 318: 389-94.
8. Nadar S, Blann AD, Lip GY. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients. Am J Hypertens 2006; 19: 970-7.